tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 162 are a BUY (79.02%), 43 are a HOLD (20.98%).
Analyst Michael Schmidt, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 49.2% that have a potential upside of 35.53% achieved within 225 days.
Michael Schmidt’s has documented 425 price targets and ratings displayed on 52 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on GMAB, Genmab AS at 22-Sep-2025.
Analyst best performing recommendations are on IONS (IONIS PHARMACEUTICALS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 7/14/2016. The price target of $26 was fulfilled within 1 day with a profit of $1.48 (6.04%) receiving and performance score of 60.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$4
3 years 4 months 9 days ago
(13-Jun-2022)
0/11 (0%)
$2.53 (172.11%)
Hold
$4.75
$4.66 (5177.78%)
$5.75
3 years 11 months 20 days ago
(02-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
4 years 11 months 17 days ago
(05-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy
$16
$15.91 (17677.78%)
$17
5 years 2 months 16 days ago
(06-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
$4
$3.91 (4344.44%)
$3
5 years 5 months 17 days ago
(05-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
Which stock is Michael Schmidt is most bullish on?
Which stock is Michael Schmidt is most reserved on?
What Year was the first public recommendation made by Michael Schmidt?
